Osteoporosis

The key cellular issue is a mismatch between osteoclast and osteoblast activity. Osteoclasts resorb, or remove, bone, whereas osteoblasts build new bone. When resorption exceeds formation over time, the skeleton loses mineral density and its internal structure becomes less robust. This imbalance provides the mechanistic basis for increased fracture vulnerability and guides therapies designed to reduce bone loss or promote formation.

Bone strength reflects more than a density value. In osteoporosis, reduced bone mineral density occurs alongside deterioration of bone microarchitecture, meaning the organization of bone’s internal structure is also compromised. Considering both changes helps explain why the condition is evaluated as a disorder of overall skeletal strength rather than as an isolated measurement abnormality.

The clinical importance of osteoporosis lies in the increased vulnerability of weakened bones to fractures. These injuries can threaten mobility and quality of life, making preservation of physical function an important treatment objective. Consequently, care addresses both skeletal strength and fall-risk reduction, rather than focusing only on the bone measurement obtained during evaluation.

Assessment combines several sources of information rather than relying on a single test. Clinicians review medical history, perform a physical evaluation, and measure bone mineral density when appropriate. Dual-energy X-ray absorptiometry is commonly used for this measurement. Together, these elements help clinicians evaluate skeletal status and inform decisions about prevention or treatment.

A prevention plan can combine weight-bearing exercise, adequate calcium and vitamin D, and measures that reduce fall risk. These approaches address different contributors to outcomes: exercise and nutrient adequacy support bone health, while fall-risk reduction helps limit situations that could lead to fractures. Used together, they support preservation of mobility and quality of life.

Medication choices can target the remodeling imbalance in two broad ways. Some treatments reduce bone loss by limiting excessive resorption, while others promote bone formation to support skeletal strength. Clinicians use these approaches alongside preventive measures and ongoing assessment, with the goal of preserving bone strength, lowering fracture vulnerability, and maintaining mobility and quality of life.